Otulfi
NDC 65219-828, ustekinumab-aauz, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-828
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761379
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-828 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- USTEKINUMAB130 mg/26mL
Pharmacologic classes
Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-828-05 | 65219082805 | 1 VIAL in 1 CARTON (65219-828-05) / 26 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/853130e5-7406-4fd6-8138-ff2179195927Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65219-828
Use it
Look up 65219-828 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-828 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-828. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.